Rachel L. Schweers
Katten Muchin Rosenman LLPGeneral
Experience20 yrs
Elite Ratings
--
Practice Areas
Biotech (14 cases)
Chemical Biotech (1 case)
Ratings
Experience
Grade
Trend
DCT
L1
D
PTAB
--
--
--
CAFC
--
--
--
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 1:24-CV-00064 | Eagle Pharma Inc v. Apotex Inc | 01/17/24 | Challenger | |
| 1:23-CV-00327 | Bayer IP GmbH v. Apotex Inc | 03/24/23 | Challenger | |
| 2:22-CV-07357 | Astellas Pharma Inc v. Sun Pharmaceutical Industries Inc | 12/16/22 | Challenger | |
| 1:22-CV-01596 | Bayer Pharma AG v. Apotex Inc | 12/14/22 | Challenger | |
| 2:22-CV-00216 | UCB Inc v. Mylan Tech Inc | 12/12/22 | Challenger | |
| 1:21-MD-03017 | In re: Xarelto (Rivaroxaban) ('310) Patent Litigation | 12/10/21 | ||
| 1:21-CV-01256 | Eagle Pharma Inc v. Slayback Pharma LLC | 08/31/21 | ||
| 1:21-CV-00839 | PF Prism Imb BV v. Mylan Pharma Inc | 06/09/21 | Challenger | |
| 1:21-CV-00314 | Bayer Pharma AG v. Lupin Ltd | 03/01/21 | ||
| 1:21-CV-00187 | Bial Portela & Ca SA v. Apotex Inc | 02/10/21 | Challenger |